Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology

Metabolic alterations precede cardiometabolic disease onset. Here we present ceramide- and dihydroceramide-profiling data from a nested case-cohort (type 2 diabetes [T2D, n = 775]; cardiovascular disease [CVD, n = 551]; random subcohort [n = 1137]) in the prospective EPIC-Potsdam study. We apply the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittenbecher, C., Cuadrat, R., Johnston, L., Eichelmann, F., Jäger, S., Kuxhaus, O., Prada, M., Del Greco M., F., Hicks, A. A., Hoffman, P., Krumsiek, J., Hu, F. B., Schulze, M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854598/
https://www.ncbi.nlm.nih.gov/pubmed/35177612
http://dx.doi.org/10.1038/s41467-022-28496-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854598/
https://www.ncbi.nlm.nih.gov/pubmed/35177612
http://dx.doi.org/10.1038/s41467-022-28496-1

Ejemplares similares